Cyteir Therapeutics Inc. (CYT)

AI Score

Unlock

3.02

-0.07 (-2.27%)

At close: Mar 15, 2024, 8:00 PM

Cyteir Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	100K	100K	308K	326K	200K	200K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	-100K	-100K	-308K	-326K	-200K	-200K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-5.17M	-9.61M	-13.42M	-10.05M	-11.76M	-12.23M	-14.13M	-11.86M	-11.75M	-11.31M	-7.34M	-5.38M	-5.04M	-4.51M	-6.01M
Interest Income	1.64M	1.2M	1.54M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-3.53M	-8.4M	-12.49M	-8.79M	-11.04M	-12.12M	-14.1M	-11.81M	-11.7M	-11.29M	-7.31M	-5.36M	-5.04M	-4.5M	-5.93M
Net Income	-3.53M	-8.4M	-11.55M	-7.4M	-10.33M	-12.02M	-14.07M	-11.81M	-11.7M	-11.29M	-7.31M	-5.36M	-5.04M	-4.5M	-5.93M
Selling & General & Admin	2.5M	4.2M	4.11M	2.58M	3.49M	3.43M	4.04M	3.61M	3.55M	2.42M	1.72M	1.46M	831K	875K	1.01M
Research & Development	2.68M	5.4M	9.31M	7.47M	8.27M	8.79M	10.09M	8.26M	8.21M	8.89M	5.61M	3.92M	4.21M	3.63M	5M
Other Expenses	n/a	n/a	n/a	1.26M	714K	106K	29K	47K	48K	13K	25K	20K	9K	10K	81K
Operating Expenses	5.17M	9.61M	13.42M	10.05M	11.76M	12.23M	14.13M	11.86M	11.75M	11.31M	7.34M	5.38M	5.04M	4.51M	6.01M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	5.17M	9.61M	13.42M	10.05M	11.76M	12.23M	14.13M	11.86M	11.75M	11.31M	7.34M	5.38M	5.04M	4.51M	6.01M
Income Tax Expense	n/a	n/a	-936K	-1.4M	-714K	-106K	-29K	-140K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	36.03M	35.74M	35.59M	35.38M	35.33M	35.28M	35.24M	35.14M	35.06M	2.34M	34.47M	23.89M	23.89M	23.89M	23.89M
Shares Outstanding (Diluted)	36.03M	35.74M	35.59M	35.38M	35.33M	35.28M	35.24M	35.14M	35.06M	2.34M	34.47M	23.89M	23.89M	23.89M	23.89M
EPS (Basic)	-0.1	-0.24	-0.32	-0.21	-0.29	-0.34	-0.4	-0.34	-0.33	-4.83	-0.21	-0.22	-0.21	-0.19	-0.25
EPS (Diluted)	-0.1	-0.24	-0.32	-0.21	-0.29	-0.34	-0.4	-0.34	-0.33	-4.83	-0.21	-0.22	-0.21	-0.19	-0.25
EBITDA	-5.06M	-9.5M	-13.42M	-9.88M	-11.59M	-12.06M	-13.97M	-11.86M	-11.63M	-11.2M	-7.23M	-5.29M	-4.94M	-4.43M	-5.94M
EBIT	n/a	n/a	n/a	-8.83M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	110K	108K	607K	170K	170K	169K	159K	140K	125K	111K	103K	95K	107K	82K	67K